Pharmacological treatment of negative symptoms of schizophrenia: Therapeutic opportunity or Cul-de-sac?

P. F. Buckley, S. M. Stahl

Research output: Contribution to journalReview articlepeer-review

131 Scopus citations


Objective: Negative symptoms of schizophrenia are debilitating and they contribute to poor outcome in schizophrenia. Initial enthusiasm that second-generation antipsychotics would prove to be powerful agents to improve negative symptoms has given way to relative pessimism that the effects of current pharmacological treatments are at best modest. Method: A review of the current 'state-of-play' of pharmacological treatments for negative symptoms in schizophrenia. Results: Treatment results to date have been largely disappointing. The evidence for efficacy of second-generation antipsychotics is reviewed. Conclusion: The measurement and treatment trials methodology for the evaluation of negative symptoms need additional refinement before therapeutic optimism that better treatments for negative symptoms can be realized.

Original languageEnglish (US)
Pages (from-to)93-100
Number of pages8
JournalActa Psychiatrica Scandinavica
Issue number2
StatePublished - Feb 2007


  • Antipsychotic medications
  • Measurement
  • Negative symptoms

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Pharmacological treatment of negative symptoms of schizophrenia: Therapeutic opportunity or Cul-de-sac?'. Together they form a unique fingerprint.

Cite this